1. Home
  2. LXU vs FTH Comparison

LXU vs FTH Comparison

Compare LXU & FTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LSB Industries Inc.

LXU

LSB Industries Inc.

HOLD

Current Price

$11.54

Market Cap

880.5M

Sector

Industrials

ML Signal

HOLD

Logo Faeth Therapeutics Inc. Common Stock

FTH

Faeth Therapeutics Inc. Common Stock

N/A

Current Price

$37.84

Market Cap

835.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LXU
FTH
Founded
1968
N/A
Country
United States
United States
Employees
513
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
880.5M
835.7M
IPO Year
2006
2021

Fundamental Metrics

Financial Performance
Metric
LXU
FTH
Price
$11.54
$37.84
Analyst Decision
Hold
Analyst Count
4
0
Target Price
$14.63
N/A
AVG Volume (30 Days)
661.3K
277.5K
Earning Date
04-29-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
225.93
N/A
EPS
0.18
N/A
Revenue
$615,208,000.00
N/A
Revenue This Year
$13.69
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$65.00
N/A
Revenue Growth
17.77
N/A
52 Week Low
$7.71
$17.50
52 Week High
$17.22
$42.14

Technical Indicators

Market Signals
Indicator
LXU
FTH
Relative Strength Index (RSI) 62.08 63.90
Support Level $11.54 $31.03
Resistance Level $12.39 N/A
Average True Range (ATR) 0.49 3.31
MACD 0.14 0.32
Stochastic Oscillator 79.79 75.49

Price Performance

Historical Comparison
LXU
FTH

About LXU LSB Industries Inc.

LSB Industries Inc is engaged in the manufacturing and sale of chemical products in the United States. The company manufactures and sells chemical products for the agricultural and industrial sectors. Its products include ammonia, fertilizer grade ammonium nitrate (AN and HDAN), and urea ammonia nitrate (UAN) for agricultural applications; high purity and commercial grade ammonia, sulfuric acids, concentrated, blended, and regular nitric acid, mixed nitrating acids, carbon dioxide, and diesel exhaust fluid for industrial applications; and industrial grade AN (LDAN) and AN solutions for mining applications. Its products are sold through distributors and directly to end customers throughout the United States and other parts of North America.

About FTH Faeth Therapeutics Inc. Common Stock

Faeth Therapeutics Inc is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways. The company's principal program is PIKTOR, an investigational all-oral combination of serabelisib and sapanisertib in development for endometrial and breast cancer.

Share on Social Networks: